5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide
C24H22ClN3O6S2 — CID 58132395
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide
5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide (PubChem CID 58132395) has the molecular formula C24H22ClN3O6S2 and a molecular weight of 548.04 g/mol. Its IUPAC name is 5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide.
Molecular Properties
| Compound Name | 5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide |
|---|---|
| PubChem CID | 58132395 |
| Molecular Formula | C24H22ClN3O6S2 |
| Molecular Weight | 548.04 g/mol |
| Exact Mass | 547.06 |
| IUPAC Name | 5-chloro-1-ethyl-N-[3-(methylsulfonylmethyl)phenyl]sulfonyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxamide |
| SMILES | CCn1c(C(=O)NS(=O)(=O)c2cccc(CS(C)(=O)=O)c2)c(-c2ccc[nH]c2=O)c2cc(Cl)ccc21 |
| InChI | InChI=1S/C24H22ClN3O6S2/c1-3-28-20-10-9-16(25)13-19(20)21(18-8-5-11-26-23(18)29)22(28)24(30)27-36(33,34)17-7-4-6-15(12-17)14-35(2,31)32/h4-13H,3,14H2,1-2H3,(H,26,29)(H,27,30) |
| InChIKey | UBEGSMSCGFOFPN-UHFFFAOYSA-N |
| XLogP | 3.33 |
| TPSA | 135.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 548.04 |
| LogP ≤ 5 | 3.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58132395 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.